𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of heat-inactivated hepatitis B vaccine (CLB) in dialysis units

✍ Scribed by J. Colaert; J. Desmyter; G. Groote; M. Reynders; H. G. J. Brummelhuis; P. J. Dees; P. N. Lelie; E. E. Reerink-Brongers; H. W. Reesink


Publisher
Springer Netherlands
Year
1983
Tongue
English
Weight
135 KB
Volume
49
Category
Article
ISSN
0003-6072

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Lack of immune potentiation by complexin
✍ Dr. P. Nico Lelie; Peter J. A. J. van Amelsfoort; C. S. Martine de Groot; Ed Bak πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 324 KB πŸ‘ 1 views

In a randomized, dose-response study among 305 health care workers, we examined whether the immunogenicity of a heat-inactivated hepatitis B vaccine could be enhanced when HBsAg was complexed by anti-HBs contained in hepatitis B immunoglobulin either at equivalent proportions or at 10-fold antigen e

Inactivation of 1015 chimpanzee-infectio
✍ Dr. P. N. Lelie; H. W. Reesink; J. Niessen; B. Brotman; A. M. Prince πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 396 KB

The safety of a plasma-derived hepatitis-B vaccine inactivated by two heating steps (90 sec at 103 "C followed by 10 hr pasteurization at 65 "C) was validated in chimpanzees; 1 O3 chimpanzee-infectious doses (CID,,) of hepatitis-B virus (HBV), subjected to the purification steps during production of

Protective efficacy of hepatitis B vacci
✍ Francis E. AndrΓ©; Arie J. Zuckerman πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 890 KB

## Abstract A literature search was carried out to investigate the factors that influence the protective efficacy (PE) of hepatitis B vaccines when given to neonates of hepatitis B surface antigen and __e__ antigen positive mothers. Hepatitis B vaccines with either high or low antigen doses are ver

Inactivation of 12 viruses by heating st
✍ Dr. P. N. Lelie; H. W. Reesink; C. J. Lucas πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

The efficacy of two heating cycles (90 sec at 103 O C and 10 hr at 65 "C) used during manufacture of a plasma-derived hepatitis-B vaccine was validated for the inactivation of 12 virus families. A period of 15 min warming up to 65 O C had already completely inactivated representatives of nine virus